Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $5.31 Million - $7.36 Million
130,952 New
130,952 $6.92 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $393,245 - $523,192
10,634 Added 10.13%
115,610 $5.2 Million
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $103,879 - $169,734
-3,706 Reduced 3.41%
104,976 $3.82 Million
Q1 2022

May 11, 2022

SELL
$29.24 - $44.06 $582,548 - $877,807
-19,923 Reduced 15.49%
108,682 $4.49 Million
Q4 2021

Feb 11, 2022

SELL
$39.32 - $61.61 $2.27 Million - $3.55 Million
-57,616 Reduced 30.94%
128,605 $5.48 Million
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $1.07 Million - $1.61 Million
24,418 Added 15.09%
186,221 $10.2 Million
Q2 2021

Aug 11, 2021

BUY
$44.66 - $63.06 $2.34 Million - $3.3 Million
52,339 Added 47.81%
161,803 $7.74 Million
Q1 2021

May 13, 2021

SELL
$46.31 - $62.7 $801,579 - $1.09 Million
-17,309 Reduced 13.65%
109,464 $5.54 Million
Q4 2020

Feb 09, 2021

SELL
$55.51 - $69.94 $794,514 - $1 Million
-14,313 Reduced 10.14%
126,773 $7.98 Million
Q3 2020

Nov 12, 2020

BUY
$42.19 - $69.61 $482,484 - $796,059
11,436 Added 8.82%
141,086 $9.48 Million
Q2 2020

Aug 12, 2020

BUY
$27.55 - $43.28 $1.33 Million - $2.09 Million
48,201 Added 59.18%
129,650 $5.43 Million
Q1 2020

May 06, 2020

SELL
$23.16 - $47.8 $19,755 - $40,773
-853 Reduced 1.04%
81,449 $2.56 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $1 Million - $1.44 Million
35,754 Added 76.81%
82,302 $3.32 Million
Q3 2019

Nov 07, 2019

BUY
$31.65 - $46.94 $543,652 - $806,288
17,177 Added 58.48%
46,548 $1.51 Million
Q2 2019

Aug 12, 2019

BUY
$32.5 - $49.12 $954,557 - $1.44 Million
29,371 New
29,371 $1.42 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.